|
Overview |
Product information |
Accredo services |
Contact team
Fabrazyme acts like the naturally occurring alpha-GAL enzyme and targets GL-3 inside the cell. Once inside the cell, it breaks up GL-3 into smaller components that can then be removed from the cell by natural processes. The relationship between GL-3 reduction and the improvement of specific signs and symptoms, however, has not been established.
For more information, please visit Fabrazyme.com, or download the full prescribing information.
Fabrazyme is a registered trademark of Genzyme Corporation.
| 
